GO
Loading...

Medtronic Inc

More

  • Midday Glance: Medical Devices companies Thursday, 16 Oct 2014 | 1:21 PM ET

    Allergan fell$. 04 or percent, to $177.56. Baxter International Inc. rose$. 65 or 1.0 percent, to $68.99. Boston Scientific Corp. rose$. 02 or. 2 percent, to $11.46.

  • Early Glance: Medical Devices companies Thursday, 16 Oct 2014 | 11:35 AM ET

    Allergan fell $4.39 or 2.5 percent, to $173.20. Baxter International Inc. fell $1.01 or 1.5 percent, to $67.33. Boston Scientific Corp. fell$. 12 or 1.0 percent, to $11.33.

  • Final Glance: Medical Devices companies Wednesday, 15 Oct 2014 | 6:07 PM ET

    Allergan fell $4.40 or 2.4 percent, to $177.59. Baxter International Inc. fell$. 52 or. 8 percent, to $68.34. Boston Scientific Corp. fell$. 12 or 1.0 percent, to $11.44.

  • Midday Glance: Medical Devices companies Wednesday, 15 Oct 2014 | 1:17 PM ET

    Allergan fell $8.30 or 4.6 percent, to $173.69. Baxter International Inc. fell $1.69 or 2.5 percent, to $67.17. Boston Scientific Corp. fell$. 32 or 2.7 percent, to $11.25.

  • UPDATE 2-St. Jude Medical lowers forecast; shares fall Wednesday, 15 Oct 2014 | 1:07 PM ET

    Oct 15- Heart device maker St. Jude Medical Inc on Wednesday forecast fourth-quarter revenue below Wall Street estimates, citing soft international sales and unfavorable foreign exchange rates, and its shares fell nearly 4 percent. The maker of pacemakers, implantable defibrillators, replacement heart valves and neurological products said it expects...

  • Early Glance: Medical Devices companies Wednesday, 15 Oct 2014 | 10:46 AM ET

    Allergan fell $5.93 or 3.3 percent, to $176.06. Baxter International Inc. fell $1.10 or 1.6 percent, to $67.76. Boston Scientific Corp. fell$. 13 or 1.1 percent, to $11.43.

  • Oct 15- Major U.S. drugmaker AbbVie Inc said on Wednesday it was reconsidering a $55 billion bid for Ireland's Shire Plc, marking a setback for "inversion" deals in which U.S. companies reincorporate abroad to cut tax costs. Steris Corp said on Monday it has offered to buy Britain's Synergy Health Plc for about $1.9 billion in a deal that would shift Steris' tax...

  • Oct 15- Heart device maker St. Jude Medical Inc forecast a quarterly revenue that fell below Wall Street estimate, and said sales growth in international markets didn't match its expectation. The maker of pacemakers, implantable defibrillators, artificial heart valves, stents and neurological products said it expects an adjusted profit of $1.02- $1.04 per...

  • Shire: AbbVie should proceed with $55B acquisition Wednesday, 15 Oct 2014 | 6:44 AM ET

    The drugmaker Shire wants AbbVie to stick with its roughly $55 billion acquisition bid, and it is reminding its U.S. counterpart of the hefty breakup fee it could receive if things don't work out. Shire's U.S.-traded shares shed nearly a quarter of their value Wednesday morning, a day after AbbVie Inc. disclosed that it was reconsidering a deal it had fought for...

  • Final Glance: Medical Devices companies Tuesday, 14 Oct 2014 | 6:03 PM ET

    Allergan rose $3.71 or 2.1 percent, to $181.99. Baxter International Inc. fell$. 80 or 1.1 percent, to $68.86. Boston Scientific Corp. fell$. 18 or 1.5 percent, to $11.56.

  • Midday Glance: Medical Devices companies Tuesday, 14 Oct 2014 | 1:42 PM ET

    Allergan rose $2.64 or 1.5 percent, to $180.92. Baxter International Inc. rose$. 01 or percent, to $69.67. Boston Scientific Corp. rose$. 02 or. 2 percent, to $11.76.

  • Early Glance: Medical Devices companies Tuesday, 14 Oct 2014 | 10:27 AM ET

    Allergan fell $2.92 or 1.6 percent, to $175.36. Baxter International Inc. rose$. 02 or percent, to $69.68. Boston Scientific Corp. fell$. 06 or. 5 percent, to $11.68.

  • Midday Glance: Medical Devices companies Monday, 13 Oct 2014 | 1:19 PM ET

    Allergan fell $2.27 or 1.2 percent, to $185.35. Baxter International Inc. fell$. 52 or. 7 percent, to $70.73. Boston Scientific Corp. rose$. 08 or. 6 percent, to $12.00.

  • Early Glance: Medical Devices companies Monday, 13 Oct 2014 | 10:30 AM ET

    Allergan fell $1.25 or. 7 percent, to $186.36. Baxter International Inc. fell$. 38 or. 5 percent, to $70.87. Boston Scientific Corp. rose$. 05 or. 4 percent, to $11.97.

  • Steris to spend $1.9B on UK's Synergy Health Monday, 13 Oct 2014 | 7:01 AM ET

    Steris Corp. will spend about $1.9 billion to buy a British sterilization services company, as U.S. businesses continue to seek overseas incorporations despite attempts to make such tax-saving maneuvers less lucrative. The medical products maker said Monday that the new company created by its combination with Synergy Health PLC will keep operational...

  • Oct 5- Medical equipment supplier Becton Dickinson& Co has agreed to buy CareFusion Corp, a maker of infusion pumps and other medical devices, for $12.2 billion in cash and stock, marking the latest multibillion-dollar healthcare sector deal. Becton said on Sunday it would pay a total of $58.00 a share- $49.00 in cash and 0.0777 of a share of Becton Dickinson- for...

  • NEW YORK, Oct 3- Covidien Plc and Medtronic Inc both rallied on Friday, with the names moving on heavy volume after Medtronic affirmed its commitment to buy Dublin- based Covidien. Medtronic did change the structure of the deal, saying it would use $16 billion in debt rather than cash held overseas, reacting to changes made by U.S. tax authorities to cut the benefits...

  • Oct 3- U.S. medical equipment maker Medtronic Inc said it would still buy Covidien Plc but would use $16 billion in debt rather than cash held overseas, reacting to new U.S. Medtronic stock rose 3.6 percent to $65.06, while Covidien gained 5.6 percent to $93.78. Medtronic in June announced plans to buy Ireland's Covidien for cash and stock worth $43 billion.

  • Midday Movers: Media General, Noble, Yodlee & More Friday, 3 Oct 2014 | 12:10 PM ET

    Take a look at some of Friday's midday movers.

  • Oct 3- U.S. medical equipment maker Medtronic Inc said it would still buy Covidien Plc but will use $16 billion in debt rather than cash held overseas, reacting to changes made by U.S. tax authorities to cut the benefits of such "inversion deals." Medtronic in June announced plans to buy Ireland's Covidien for cash and stock worth $43 billion. Medtronic said on Friday...